Director Quality Risk Management - Remote US
McKesson Corporation | |
United States, Tennessee | |
Jan 07, 2025 | |
It's More Than a Career, It's a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day. Our Mission People who live with cancer - those who work to prevent it, fight it, and survive it - are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world. We are seeking a highly skilled and experienced Director of Quality Risk Management to join our Quality Assurance (QA) department, specifically overseeing clinical research. This newly created role is integral to our commitment to incorporating Quality by Design (QbD) into our clinical research programs, in alignment with the ICH Q9 and ICH E6as well as Food and Drug Administration (FDA) and European Medicinal Agency (EMA) guidelines on risk management. The Director will work closely with therelevant stakeholders for establishing processes for management (identification, analyzation, control, communication, review and reporting of risks) of critical to quality factors holistically.Establishes and oversees their execution ofcollaboration, communication and escalation pathways with CRAs, Central Monitors, Data Management, vendors, process owners and others as needed to analyze risks and issues using quality performance data, to identify follow up actions and to oversee completion of identified actions. This position will also support governance and oversight of system level risk management in collaboration with SCRI IT, Validation and quality assurance teams, including QA audit. Duties include and are not limited to: Strategic Leadership
Quality by Design (QbD)
Risk Identification, Analyzation, and Mitigation
KPIs KRIs and Performance Metrics
As well as Oversight, Partnership and Collaboration, Training and Development, and Continuous Improvement Qualifications needed and preferred include:
About Sarah Cannon Research Institute Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI's research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings. We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status. |